Medindia LOGIN REGISTER
Medindia
Advertisement

Sahm Adrangi's Kerrisdale Capital Issues Negative Report on Proteostasis Therapeutics, Inc., and Announces Conference-Call Schedule

Tuesday, March 20, 2018 General News
Advertisement
- Kerrisdale believes that Proteostasis Therapeutics' investigational cystic-fibrosis drug, PTI-428, is ineffective and will fail future Phase 3 trials
Advertisement

NEW YORK, March 20, 2018 /PRNewswire/ -- Kerrisdale Capital, a private investment manager, has published a negative report explaining its short position in Proteostasis Therapeutics, Inc. (NASDAQ: PTI), a development-stage biopharmaceutical company whose market value is based primarily on PTI-428, its lead drug candidate for the treatment of cystic fibrosis. Proteostasis's stock price increased ~100% after the FDA granted the drug Breakthrough Therapy and Orphan Drug designations, but Kerrisdale's analysis demonstrates that PTI-428 is likely ineffective. Kerrisdale also details a pattern of low-quality data and troubling omissions in Proteostasis's public disclosures.
Advertisement

The full report can be found at http://kerr.co/pti.

Kerrisdale has a short position in Proteostasis Therapeutics, Inc., and stands to benefit if its share price falls.

Conference Call ScheduleKerrisdale will host a conference call on Tuesday, March 20 at 10:30am ET to discuss the Proteostasis report.

To participate in the conference call, dial (866) 834-3313 (United States) or (409) 981-0700 (international) and reference the Kerrisdale Capital call.

About Kerrisdale CapitalKerrisdale Capital Management, LLC, is a fundamentally-oriented investment manager that focuses on long-term value investments and event-driven special situations.

ContactAgnes CaoKerrisdale Capital [email protected] 212-257-4385

Kerrisdale Capital Management, LLC is a member of the Financial Industry Regulatory Authority, CRD number 160804.

Cision View original content:http://www.prnewswire.com/news-releases/sahm-adrangis-kerrisdale-capital-issues-negative-report-on-proteostasis-therapeutics-inc-and-announces-conference-call-schedule-300616553.html

SOURCE Kerrisdale Capital Management, LLC

Sponsored Post and Backlink Submission


Latest Press Release on General News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close